Joseph Aslan։ Targeting Mitochondrial Permeability Transition To Reduce Platelet Thrombogenicity
Joseph Aslan, Associate Professor at Oregon Health and Science University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood, adding:
”Happy to share our paper, now online as a Blood First Edition article, led by graduate student Yiheng Zhang.
We characterized small molecule inhibitors of the mitochondrial permeability transition pore (mPTP) that selectively suppress platelet procoagulant activity and limit thrombosis while preserving key platelet functions, including aggregation and secretion.
Grateful to Yiheng, Jordan, Vrishank, Moua Yang, Owen McCarty, Michael Cohen and all our Oregon Health and Science University and Oregon State University and other collaborators for their contributions to this work.
Read the paper ‘Inhibition of mitochondrial permeability transition selectively suppresses thrombogenic platelet procoagulant activity’ ”
Title: Inhibition of mitochondrial permeability transition selectively suppresses thrombogenic platelet procoagulant activity
Authors: Yiheng Zhang, Jordan Sandler, Osamede Clinton Owegie, Xu Zhang, Vrishank Shivaprakash, Jack Kurth, Yong Sun, Mayu Morita, Raquel Mote, Neva Scott, Gavin Hutchison, Eliana Choi, Helena Ventosa-Capell, Jiaqing Pang, Cristina Puy, Yabing Chen, Terry Morgan, Owen JT McCarty, Moua Yang, Michael Cohen, Joseph E Aslan

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series